unknown
Stage
1
Investors
About
Erisyon develops the world's first single-molecule protein sequencer using a technology called Fluorosequencing to enable highly sensitive, massively parallel, and quantitative proteomics for earlier disease detection and treatment.
Explore Erisyon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.